{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:54:21Z","timestamp":1770882861289,"version":"3.50.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Living donor liver transplantation is the main source of organs in the Middle East. Therefore, well balanced criteria are needed to avoid unnecessary exclusion of potential donors, while prioritizing donor safety. We face a high incidence of sickle cell trait (SCT; and disease). Therefore, there is vast experience in general and cardiac surgeries in SCT carriers at our center. After studying their management in detail, we considered accepting SCT carriers as living liver donors, on an exceptional basis. This the first single-center case series of living donor liver transplantation with SCT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Between January 2012 and September 2021, 20 donors with SCT were reviewed for age, gender, relation to the recipient, hemoglobin, hemoglobin S (HbS), surgical approach, intensive care unit stay, donor and recipients\u2019 complications, and graft and recipient survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Average age of donors was 28.4 y. Sixteen donated the left lateral segment, 4 the left lobe. Recipients were related children or adults. HbS ranged from 21.2% to 39.9%, being \u226530% in 14 donors. HbS was reduced by phlebotomy or exchange transfusion. We performed 7 open, one laparoscopic, and 12 robotic donor surgeries. Operating room time, blood loss, and intensive care unit stay were comparable to non-SCT donors. There was no SCT-related complication. All donors are alive and free of thromboembolic events. Graft and recipient survival is 100% until follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion.<\/jats:title>\n            <jats:p>Our experience should encourage other countries with high incidence of SCT to report their experience with this donor population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001332","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T21:01:58Z","timestamp":1652216518000},"page":"e1332","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["First Experience in Living Liver Donation From Donors With Sickle Cell Trait"],"prefix":"10.1097","volume":"8","author":[{"given":"Maren","family":"Schulze","sequence":"first","affiliation":[{"name":"Department of Abdominal Transplant and Hepatobiliary Surgery, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Zidan","sequence":"additional","affiliation":[{"name":"Department of Abdominal Transplant and Hepatobiliary Surgery, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Sturdevant","sequence":"additional","affiliation":[{"name":"Division of Transplant Surgery, Department of Surgery, University of Washington Medical Centre, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sultan","family":"Aljudaibi","sequence":"additional","affiliation":[{"name":"Department of Abdominal Transplant and Hepatobiliary Surgery, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Shagrani","sequence":"additional","affiliation":[{"name":"Section of Pediatric Transplant Hepatology, Department of Liver and Small Bowel Health Center, Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Bzeizi","sequence":"additional","affiliation":[{"name":"Section of Adult Transplant Hepatology, Department of Liver and Small Bowel Health Center, Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh","family":"Alqahtani","sequence":"additional","affiliation":[{"name":"Section of Adult Transplant Hepatology, Department of Liver and Small Bowel Health Center, Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter C.","family":"Broering","sequence":"additional","affiliation":[{"name":"Department of Abdominal Transplant and Hepatobiliary Surgery, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"key":"R1-20240805","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/GIM.0b013e318065a9e8","article-title":"Premarital screening for thalassemia and sickle cell disease in Saudi Arabia.","volume":"9","author":"Alhamdan","year":"2007","journal-title":"Genet Med"},{"key":"R2-20240805","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.4103\/0976-9668.166093","article-title":"Frequency distribution of sickle cell anemia, sickle cell trait and sickle\/beta-thalassemia among anemic patients in Saudi Arabia.","volume":"6","author":"Elsayid","year":"2015","journal-title":"J Nat Sci Biol Med"},{"key":"R3-20240805","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/0256-4947.81540","article-title":"Epidemiology of sickle cell disease in Saudi Arabia.","volume":"31","author":"Jastaniah","year":"2011","journal-title":"Ann Saudi Med"},{"key":"R4-20240805","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bjsports-2011-090896","article-title":"Sickle cell trait associated with a RR of death of 37 times in National Collegiate Athletic Association football athletes: a database with 2 million athlete-years as the denominator.","volume":"46","author":"Harmon","year":"2012","journal-title":"Br J Sports Med"},{"key":"R5-20240805","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ejmhg.2014.08.008","article-title":"The scope of clinical morbidity in sickle cell trait.","volume":"15","author":"Tantawy","year":"2014","journal-title":"Egypt J Med Hum Genet"},{"key":"R7-20240805","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/00005768-199608000-00001","article-title":"Risk factors predicting exertional heat illness in male Marine Corps recruits.","volume":"28","author":"Gardner","year":"1996","journal-title":"Med Sci Sports Exerc"},{"key":"R8-20240805","first-page":"354","article-title":"Exertional heat illness in Marine Corps recruit training.","volume":"67","author":"Kark","year":"1996","journal-title":"Aviat Space Environ Med"},{"key":"R9-20240805","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM198709243171301","article-title":"Sickle-cell trait as a risk factor for sudden death in physical training.","volume":"317","author":"Kark","year":"1987","journal-title":"N Engl J Med"},{"key":"R10-20240805","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1055\/s-0036-1592333","article-title":"Environmental and genetic risk factors associated with venous thromboembolism.","volume":"42","author":"Crous-Bou","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"R11-20240805","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCULATIONAHA.109.882464","article-title":"Open heart surgery in patients with sickle cell hemoglobinopathy.","volume":"121","author":"Yousafzai","year":"2010","journal-title":"Circulation"},{"key":"R12-20240805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.6002\/ect.2011.0098","article-title":"Sickle cell and renal transplant: a national survey and literature review.","volume":"10","author":"Nath","year":"2012","journal-title":"Exp Clin Transplant"},{"key":"R13-20240805","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1432-2277.2007.00611.x","article-title":"Screening for sickle trait among potential live kidney donors: policies and practices in US transplant centers.","volume":"21","author":"Reese","year":"2008","journal-title":"Transpl Int"},{"key":"R14-20240805","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1096-8652(200004)63:4<205::AID-AJH8>3.0.CO;2-8","article-title":"Renal abnormalities in sickle cell disease.","volume":"63","author":"Ataga","year":"2000","journal-title":"Am J Hematol"},{"key":"R15-20240805","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000019703","article-title":"Massive gross hematuria in a sickle cell trait patient with renal papillary necrosis. Conservative approach using a balloon ureteral catheter to tamponade the papilla bleeding.","volume":"34","author":"Herard","year":"1998","journal-title":"Eur Urol"},{"key":"R16-20240805","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1590\/S0100-879X1998001000004","article-title":"Renal dysfunction in patients with sickle cell anemia or sickle cell trait.","volume":"31","author":"Sesso","year":"1998","journal-title":"Braz J Med Biol Res"},{"key":"R17-20240805","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1681\/ASN.V861034","article-title":"Renal papillary necrosis in a patient with sickle cell trait.","volume":"8","author":"Zadeii","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R18-20240805","first-page":"698","article-title":"Kidney transplant from sickle cell trait donor to sickle cell trait recipient.","volume":"5","author":"Rehman","year":"2007","journal-title":"Exp Clin Transplant"},{"key":"R19-20240805","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1053\/j.ajkd.2003.10.044","article-title":"Evaluation of the living kidney donor: current perspectives.","volume":"43","author":"Davis","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R20-20240805","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1056\/NEJM199507273330402","article-title":"A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group.","volume":"333","author":"Vichinsky","year":"1995","journal-title":"N Engl J Med"},{"key":"R21-20240805","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/j.jvca.2004.07.032","article-title":"Pro: exchange transfusion is required for sickle cell trait patients undergoing cardiopulmonary bypass.","volume":"18","author":"Hemming","year":"2004","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R23-20240805","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1213\/00000539-197505000-00026","article-title":"Sickling dynamics of red blood cells and other physiologic studies during anesthesia.","volume":"54","author":"Maduska","year":"1975","journal-title":"Anesth Analg"},{"key":"R24-20240805","first-page":"106","article-title":"Best practices for transfusion for patients with sickle cell disease.","volume":"1","author":"Wun","year":"2009","journal-title":"Hematol Rev"},{"key":"R25-20240805","doi-asserted-by":"crossref","first-page":"e29786","DOI":"10.1371\/journal.pone.0029786","article-title":"Association of coagulation activation with clinical complications in sickle cell disease.","volume":"7","author":"Ataga","year":"2012","journal-title":"PLoS One"},{"key":"R26-20240805","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1160\/TH07-03-0221","article-title":"Hypercoagulability after partial liver resection.","volume":"98","author":"Bezeaud","year":"2007","journal-title":"Thromb Haemost"},{"key":"R27-20240805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5500\/wjt.v2.i1.1","article-title":"Live liver donors: are they at a higher risk for post-operative thrombotic complications?","volume":"2","author":"Hilmi","year":"2012","journal-title":"World J Transplant"},{"key":"R28-20240805","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/03630269.2013.832689","article-title":"The risk of potential thromboembolic, renal and cardiac complications of sickle cell trait.","volume":"38","author":"Bucknor","year":"2014","journal-title":"Hemoglobin"},{"key":"R29-20240805","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1182\/blood-2006-11-057604","article-title":"Sickle cell trait and the risk of venous thromboembolism among blacks.","volume":"110","author":"Austin","year":"2007","journal-title":"Blood"},{"key":"R30-20240805","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/jama.1974.03230460028015","article-title":"The sickle cell trait and surgical complications. A matched-pair patient analysis.","volume":"229","author":"Atlas","year":"1974","journal-title":"JAMA"},{"key":"R31-20240805","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/thx.37.7.486","article-title":"Open-heart surgery in sickle-cell haemoglobinopathies: report of 15 cases.","volume":"37","author":"M\u00e9tras","year":"1982","journal-title":"Thorax"},{"key":"R32-20240805","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/bmj.4.5840.596","article-title":"Anaesthesia in sickle-cell states: a plea for simplicity.","volume":"4","author":"Oduro","year":"1972","journal-title":"Br Med J"},{"key":"R22-20240805","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1053\/j.jvca.2004.07.031","article-title":"Con: exchange transfusion is not required for sickle cell trait patients undergoing cardiopulmonary bypass.","volume":"18","author":"Messent","year":"2004","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R33-20240805","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1213\/00000539-199909000-00010","article-title":"Fast-track cardiac anesthesia in patients with sickle cell abnormalities.","volume":"89","author":"Djaiani","year":"1999","journal-title":"Anesth Analg"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T05:01:30Z","timestamp":1722834090000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001332","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,9]]}}}